Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boyer

Showing results (411-420 of 428) with videos related to

Pageof 43
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|May 15, 2025
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension StudyRoger A Goldberg, David S Boyer, Frank G Holz, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 29, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical TrialDavid S Boyer, Victor H Gonzalez, Derek Y Kunimoto, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Microbial Ecology|March 18, 2017
Significant Change in Marine Plankton Structure and Carbon Production After the Addition of River Water in a Mesocosm ExperimentE Fouilland, A Trottet, C Alves-de-Souza, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 29, 2025
Initiation of a global consortium to study the progression of age-related macular degeneration: RIMR AMD consortium report # 1Srinivas R Sadda, Charles C Wykoff, Itay Chowers, et al.
Ophthalmology|September 22, 2016
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesJeffrey S Heier, Jean-François Korobelnik, David M Brown, et al.
Therapeutic Advances in Ophthalmology|July 14, 2025
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDavid M Brown, David S Boyer, Diana V Do, et al.
Eclinicalmedicine|August 21, 2025
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialByron L Lam, Vitaliy Zak, Victor H Gonzalez, et al.
Therapeutic Advances in Ophthalmology|July 6, 2026
Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDiana V Do, Charles C Wykoff, Sobha Sivaprasad, et al.
Pageof 43

Showing results (411-420 of 428) with videos related to

Sort By:
Pageof 43
Ophthalmic Surgery, Lasers & Imaging Retina|May 15, 2025
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension StudyRoger A Goldberg, David S Boyer, Frank G Holz, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 29, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical TrialDavid S Boyer, Victor H Gonzalez, Derek Y Kunimoto, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialMohammad Azab, David S Boyer, Neil M Bressler, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Microbial Ecology|March 18, 2017
Significant Change in Marine Plankton Structure and Carbon Production After the Addition of River Water in a Mesocosm ExperimentE Fouilland, A Trottet, C Alves-de-Souza, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 29, 2025
Initiation of a global consortium to study the progression of age-related macular degeneration: RIMR AMD consortium report # 1Srinivas R Sadda, Charles C Wykoff, Itay Chowers, et al.
Ophthalmology|September 22, 2016
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID StudiesJeffrey S Heier, Jean-François Korobelnik, David M Brown, et al.
Therapeutic Advances in Ophthalmology|July 14, 2025
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDavid M Brown, David S Boyer, Diana V Do, et al.
Eclinicalmedicine|August 21, 2025
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trialByron L Lam, Vitaliy Zak, Victor H Gonzalez, et al.
Therapeutic Advances in Ophthalmology|July 6, 2026
Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDiana V Do, Charles C Wykoff, Sobha Sivaprasad, et al.
Pageof 43